The Health Management & Policy Governance Lab analyzes politics and policymaking to understand how these factors contribute to our health.
Antibody Tests and Regulatory Reforms: Why Delegating Pre-Market Control to Private Companies is a Bad Idea
Europe’s experience with regulating medical devices shows why allowing companies to bring antibody tests to market without regulatory approval could do more harm than good.
What we can learn from COVID-19 transition planning in Europe?
European countries are relaxing their physical distancing measures in some of the same ways as US states, but with more social policy support.
Who are the ‘vulnerable’ when it comes to COVID-19?
For variable physical distancing measures to work as a defense against COVID-19, we need to rethink the term ‘vulnerable population’.
Why is governance important for responding to COVID-19?
The best policy ideas for tackling the pandemic won’t work unless they are supported by effective governance.